Search

Keppra

Keppra

levetiracetam

Manufacturer:

GlaxoSmithKline Indonesia
Concise Prescribing Info
Contents
Levetiracetam
Indications/Uses
Adjunctive treatment of partial onset of seizures w/ or w/o secondary generalisation in patient w/ epilepsy.
Click to view Keppra detailed prescribing information
Dosage/Direction for Use
Daily dose is administered in 2 equally divided doses. Adult & adolescent ≥16 yr Initially 500 mg twice daily, may be increased up to 1,500 mg twice daily. Dose changes can be made in 500 mg twice daily increments or decrements 2-4 wkly.
Click to view Keppra detailed prescribing information
Overdosage
View Keppra overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to levetiracetam or other pyrrolidones derivatives.
Click to view Keppra detailed prescribing information
Special Precautions
Abrupt discontinuation. Renal & severe hepatic impairment. May affect ability to drive or operate machinery. Pregnancy & lactation. Elderly.
Click to view Keppra detailed prescribing information
Adverse Reactions
Asthenia; somnolence; headache, dizziness, tremor; depression, insomnia, nervousness; diarrhoea, dyspepsia, nausea; anorexia; vertigo; diplopia; accidental injury.
Click to view Keppra detailed prescribing information
Storage
View Keppra storage conditions for details to ensure optimal shelf-life.
Description
View Keppra description for details of the chemical structure and excipients (inactive components).
Action
View Keppra mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Anticonvulsants
ATC Classification
N03AX14 - levetiracetam ; Belongs to the class of other antiepileptics.
Presentation/Packing
Form
Keppra FC tab 250 mg
Packing/Price
30's
Form
Keppra FC tab 500 mg
Packing/Price
20's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in